Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosageChun‐Jen Liu, Pei‐Jer Chen, Rey‐Heng Hu et al.|Journal of Hepatology|2009Cited by 157
Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrenceKun‐Ming Chan, Miin‐Fu Chen, Yi-Yin Jan et al.|BMC Gastroenterology|2018Cited by 102
Using indocyanine green test to avoid post-hepatectomy liver dysfunction.Chen‐Fang Lee, Wei‐Chen Lee, Ming‐Chin Yu et al.|PubMed|2007Cited by 33
Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resectionKun‐Chun Chiang, Tsann‐Long Hwang, Wei‐Chen Lee et al.|World Journal of Gastroenterology|2009Cited by 23
Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected PatientsChun‐Yi Tsai, Chun‐Nan Yeh, Shang‐Yu Wang et al.|Journal of Personalized Medicine|2022Cited by 3